16 July 2023: Clinical Research
A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy
Hanzhao Yang CDE , Yadong Sun BCD , Peili Wang BD , Jianghua Qiao BC , Lianfang Li B , Zhenduo Lu B , Xianfu Sun B , Chongjian Zhang B , Xiuchun Chen B , Min Yan B , Shude Cui B , Chengzheng Wang ADF , Zhenzhen Liu AE*DOI: 10.12659/MSM.940124
Med Sci Monit 2023; 29:e940124
Figure 3 The DCA curve demonstrates the clinical efficacy of the nomogram. The red line is a nomogram predicting the risk of ≥4 positive nodes in patients. The grey line indicates all patients with ≥4 positive nodes, while the black line indicates no patient with ≥4 positive nodes. This DCA could provide a larger net benefit, with ranges of 5% to 54%. DCA – decision curve analysis. R software 4.1.1 (The R Foundation for Statistical Computing, Austria, Vienna).